The company has since learned the cyberattack was caused by a third-party contractor’s user session within its cloud-based system being compromised.

Xeltis has reached over 50% enrolment in its US pivotal trial of aXess, a vascular access device designed for adults with end-stage renal disease who require haemodialysis.

Hyperfine has commercially launched its next-generation Swoop portable MRI system (Model 2) in select European markets.

Aurenar’s V-Link system uses transauricular vagus nerve stimulation to modulate brain inflammation in patients that have experienced a stroke.

Funds will support Materna’s completion of a pivotal trial evaluating its system for reducing pelvic floor muscle injury during childbirth, as well as other commercial activities.

Artivion has received the PMA clearance from the US FDA for AMDS Hybrid Prosthesis device, permitting its use in treating acute DeBakey Type I aortic dissections with clinical or radiographic ...

The initiative is designed to simplify the ability for GE HealthCare customers with existing interventional suites to access new technologies.

Medicina supplied devices bearing false CE markings to healthcare providers including National Health Service (NHS) Trusts across the UK.

Experts at HLTH Europe 2026 agreed that healthcare innovations won't meet their full potential until healthcare services can implement them.

OrthAlign has completed the first clinical procedures using its Lantern ASC system, designed for the ASC setting.

Novocure has received CE Mark for Optune Pax, its portable medical device intended to treat adults with locally advanced pancreatic cancer of exocrine origin.

The test is designed for individuals aged 45 and above who are at average risk for cancer. Credit: tilialucida / Shutterstock.com. Zydus Lifesciences has entered a memorandum of understanding (MoU) ...